The current financial score of Ardent Health Partners Inc is 7.77. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.62B, representing a year-over-year decrease of 1.40%, while its net profit experienced a year-over-year decrease of 76.83%.
The current valuation score of Ardent Health Partners Inc is 9.28. Its current P/E ratio is 11.18, which is 465.11% below the recent high of 63.20 and 52.11% above the recent low of 5.36.
The current earnings forecast score of Ardent Health Partners Inc is 7.50. The average price target is 12.73, with a high of 14.00 and a low of 10.50.
The current price momentum score of Ardent Health Partners Inc is 2.90. Currently, the stock price is trading between the resistance level at 11.34 and the support level at 10.15, making it suitable for range-bound swing trading.
The current institutional shareholding score of Ardent Health Partners Inc is 7.00. The latest institutional shareholding proportion is 74.65%, representing a quarter-over-quarter decrease of 2.06%. The largest institutional shareholder is HOTCHKIS & WILEY, holding a total of 444.90K shares, representing 0.01% of shares outstanding, with 1.51% increase in holdings.
The current risk assessment score of Ardent Health Partners Inc is 5.03. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.